栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/01/17 | 2,143 | 2,164 | 2,143 | 2,148 | +1 | ±0% | 88,400 |
2025/01/16 | 2,151 | 2,163 | 2,144 | 2,147 | -4 | -0.2% | 104,200 |
2025/01/15 | 2,159 | 2,187 | 2,146 | 2,151 | -5 | -0.2% | 126,800 |
2025/01/14 | 2,143 | 2,170 | 2,142 | 2,156 | +3 | +0.1% | 105,600 |
2025/01/10 | 2,150 | 2,166 | 2,145 | 2,153 | -9 | -0.4% | 79,200 |
2025/01/09 | 2,151 | 2,170 | 2,147 | 2,162 | -1 | ±0% | 97,700 |
2025/01/08 | 2,179 | 2,185 | 2,154 | 2,163 | -16 | -0.7% | 82,200 |
2025/01/07 | 2,150 | 2,182 | 2,142 | 2,179 | +34 | +1.6% | 78,200 |
2025/01/06 | 2,178 | 2,199 | 2,143 | 2,145 | ±0 | ±0% | 150,100 |
2024/12/30 | 2,190 | 2,221 | 2,142 | 2,145 | -20 | -0.9% | 98,300 |
2024/12/27 | 2,169 | 2,184 | 2,145 | 2,165 | -4 | -0.2% | 134,000 |
2024/12/26 | 2,192 | 2,194 | 2,157 | 2,169 | -23 | -1% | 122,500 |
2024/12/25 | 2,206 | 2,211 | 2,164 | 2,192 | -19 | -0.9% | 81,900 |
2024/12/24 | 2,257 | 2,269 | 2,203 | 2,211 | -13 | -0.6% | 131,800 |
2024/12/23 | 2,180 | 2,242 | 2,175 | 2,224 | +74 | +3.4% | 180,100 |
2024/12/20 | 2,173 | 2,185 | 2,150 | 2,150 | -23 | -1.1% | 138,900 |
2024/12/19 | 2,156 | 2,197 | 2,150 | 2,173 | +17 | +0.8% | 149,500 |
2024/12/18 | 2,185 | 2,207 | 2,156 | 2,156 | -47 | -2.1% | 140,000 |
2024/12/17 | 2,200 | 2,222 | 2,179 | 2,203 | +17 | +0.8% | 100,000 |
2024/12/16 | 2,150 | 2,198 | 2,144 | 2,186 | +42 | +2% | 90,200 |
2024/12/13 | 2,102 | 2,165 | 2,095 | 2,144 | +7 | +0.3% | 174,400 |
2024/12/12 | 2,146 | 2,161 | 2,134 | 2,137 | -9 | -0.4% | 117,300 |
2024/12/11 | 2,187 | 2,190 | 2,141 | 2,146 | -53 | -2.4% | 153,600 |
2024/12/10 | 2,219 | 2,230 | 2,168 | 2,199 | +9 | +0.4% | 101,400 |
2024/12/09 | 2,145 | 2,204 | 2,145 | 2,190 | +45 | +2.1% | 113,100 |
2024/12/06 | 2,164 | 2,165 | 2,117 | 2,145 | -7 | -0.3% | 106,400 |
2024/12/05 | 2,150 | 2,165 | 2,126 | 2,152 | +29 | +1.4% | 74,800 |
2024/12/04 | 2,179 | 2,215 | 2,123 | 2,123 | -68 | -3.1% | 130,500 |
2024/12/03 | 2,187 | 2,224 | 2,181 | 2,191 | +4 | +0.2% | 120,100 |
2024/12/02 | 2,217 | 2,221 | 2,166 | 2,187 | -41 | -1.8% | 95,200 |
2024/11/29 | 2,197 | 2,240 | 2,168 | 2,228 | +69 | +3.2% | 136,700 |
2024/11/28 | 2,122 | 2,164 | 2,117 | 2,159 | +27 | +1.3% | 77,600 |
2024/11/27 | 2,116 | 2,132 | 2,099 | 2,132 | +6 | +0.3% | 66,500 |
2024/11/26 | 2,096 | 2,140 | 2,096 | 2,126 | +21 | +1% | 66,200 |
2024/11/25 | 2,121 | 2,121 | 2,091 | 2,105 | +13 | +0.6% | 108,800 |
2024/11/22 | 2,104 | 2,116 | 2,092 | 2,092 | -9 | -0.4% | 90,000 |
2024/11/21 | 2,099 | 2,127 | 2,089 | 2,101 | +3 | +0.1% | 84,100 |
2024/11/20 | 2,104 | 2,114 | 2,067 | 2,098 | -6 | -0.3% | 118,900 |
2024/11/19 | 2,107 | 2,122 | 2,094 | 2,104 | ±0 | ±0% | 105,800 |
2024/11/18 | 2,122 | 2,144 | 2,093 | 2,104 | -68 | -3.1% | 121,100 |
2024/11/15 | 2,175 | 2,193 | 2,157 | 2,172 | +3 | +0.1% | 98,400 |
2024/11/14 | 2,167 | 2,209 | 2,165 | 2,169 | +2 | +0.1% | 138,800 |
2024/11/13 | 2,139 | 2,167 | 2,130 | 2,167 | +27 | +1.3% | 149,900 |
2024/11/12 | 2,150 | 2,173 | 2,129 | 2,140 | -8 | -0.4% | 108,500 |
2024/11/11 | 2,172 | 2,185 | 2,141 | 2,148 | -42 | -1.9% | 94,800 |
2024/11/08 | 2,200 | 2,223 | 2,190 | 2,190 | -18 | -0.8% | 135,600 |
2024/11/07 | 2,208 | 2,221 | 2,174 | 2,208 | +1 | ±0% | 150,700 |
2024/11/06 | 2,200 | 2,250 | 2,154 | 2,207 | -75 | -3.3% | 204,000 |
2024/11/05 | 2,328 | 2,374 | 2,282 | 2,282 | -40 | -1.7% | 162,100 |
2024/11/01 | 2,372 | 2,465 | 2,318 | 2,322 | -157 | -6.3% | 257,900 |
151~
200
件表示中 / 7025件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 247,000円 | +4.1% | -3.1% | 2.35% | 21.46倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
持田薬 | 314,500円 | +5.1% | -7.0% | 2.54% | 20.65倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 203,600円 | +3.1% | -6.5% | 2.36% | 9.45倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 152,000円 | -2.4% | -52.3% | 3.75% | 18.19倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ネクセラファーマ | 91,300円 | +20.3% | - | 0.00% | 161.88倍 | 1.25倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム